Purpose

We are looking at whether two FDA-approved medications, semaglutide and dapagliflozin, may help people stay healthier as they age. Researchers want to learn if these medications can help maintain strength, physical function, and overall health in adults ages 60 to 75. The information collected will also help researchers better understand how aging affects the body over time.

Category

IRB Number
STUDY00002818
NCT Number
-
Sponsor
-



Study Contact

Elena Volpi
210-562-6139
volpi@uthscsa.edu

Elena Volpi
210-562-6139
volpi@uthscsa.edu

Principal Investigator
Elena Volpi

Tiffany Cortes
210-450-8998
cortest@uthscsa.edu

Eloisa Martinez

martineze42@uthscsa.edu



Eligibility

Eligible Ages
60-75
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

    • Willing to follow the study intervention regimen as instructed (dapagliflozin, semaglutide or placebo)

    • Currently live independently in the community (i.e., not in a nursing home, assisted living facility, or other institutional setting)

    • Body Mass Index (BMI) between 20 and 40 kg/m²

Exclusion Criteria


    Study Design

    Arm Groups